CA 19-9, a blood tumor marker for pancreatic, hepatobiliary, and colorectal cancer. This tumor marker is used in diagnosis, but is more useful in the evaluation of a patient’s response to treatment and in surveillance of the disease. Abbreviation for cancer antigen 19-9.
